Found: 8
Select item for more details and to access through your institution.
Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0279996
- By:
- Publication type:
- Article
Acceptability of dual HIV/syphilis rapid test in community- and home-based testing strategy among transgender women in Buenos Aires, Argentina.
- Published in:
- International Journal of STD & AIDS, 2021, v. 32, n. 6, p. 501, doi. 10.1177/0956462420979852
- By:
- Publication type:
- Article
Home-based HIV testing: Using different strategies among transgender women in Argentina.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230429
- By:
- Publication type:
- Article
Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221653
- By:
- Publication type:
- Article
TRANSGENDER WOMEN BASELINE PROFILE IN TRANSCITAR: TRANS-SPECIFIC COHORT IN ARGENTINA.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 343
- By:
- Publication type:
- Article
Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, p. 1, doi. 10.7448/IAS.20.01.21678
- By:
- Publication type:
- Article
Dolutegravir-lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, p. 1, doi. 10.7448/IAS.20.01.21678
- By:
- Publication type:
- Article
Dolutegravir–lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study.
- Published in:
- Journal of the International AIDS Society, 2017, v. 20, n. 1, p. 1, doi. 10.7448/IAS.20.01.21678
- By:
- Publication type:
- Article